Skip to main content

News

By Jeff Lagasse | 12:34 pm | February 21, 2022
The move was made to avoid potential staffing issues and to give healthcare workers more time to comply.
By Susan Morse | 12:16 pm | February 21, 2022
The DOJ is reportedly preparing the lawsuit to block the deal.
By Jeff Lagasse | 04:04 pm | February 18, 2022
The expectation is that customers will be able to minimize the risk of missing rebate program revenue targets and receive rebate funds more quickly.
By Jeff Lagasse | 11:05 am | February 18, 2022
Costs per single treatment for drugs administered in hospitals were an average of $7,000 more than those purchased through specialty pharmacies.
By Susan Morse | 10:04 am | February 18, 2022
Mayo Clinic is able to send kidney and marrow transplant patients home to recover to a hospital level of care, says Medically Home CEO Rami Karjian.
By Susan Morse | 08:28 pm | February 17, 2022
Rhode Island will join the Federal Trade Commission's lawsuit to block the merger.
By Jeff Lagasse | 04:50 pm | February 17, 2022
With specialty drug costs projected to reach $505 billion by 2023 by the company's estimates, Optum has tapped into a potential market opportunity.
By Jeff Lagasse | 12:39 pm | February 17, 2022
Sara Serritella of the University of Chicago will spin her tale during the HIMSS22 annual conference in Orlando next month.
By Susan Morse | 12:00 pm | February 17, 2022
Opponents fear the Trump-era model will lead to the privatization of Medicare.
By Jeff Lagasse | 04:12 pm | February 16, 2022
Alcohol use has been on the rise, and nearly 60% of people have increased their drinking during the pandemic, numbers show.